Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Xenobiotics | 1 | 2019 | 71 | 0.630 |
Why?
|
| Thiosemicarbazones | 1 | 2018 | 13 | 0.610 |
Why?
|
| Copper | 1 | 2018 | 368 | 0.500 |
Why?
|
| NADP | 1 | 2016 | 229 | 0.480 |
Why?
|
| Oximes | 1 | 2016 | 303 | 0.470 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 683 | 0.380 |
Why?
|
| Computational Biology | 1 | 2021 | 3567 | 0.310 |
Why?
|
| Cell Death | 7 | 2017 | 1680 | 0.310 |
Why?
|
| Iron | 2 | 2017 | 1813 | 0.310 |
Why?
|
| Liver | 2 | 2021 | 7578 | 0.270 |
Why?
|
| Sulfonamides | 1 | 2016 | 1982 | 0.260 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13677 | 0.250 |
Why?
|
| Glutathione Peroxidase | 2 | 2017 | 259 | 0.230 |
Why?
|
| Apoptosis | 5 | 2020 | 9527 | 0.230 |
Why?
|
| Kidney | 1 | 2019 | 7064 | 0.220 |
Why?
|
| Glioblastoma | 1 | 2018 | 3464 | 0.210 |
Why?
|
| Neoplasms | 5 | 2021 | 22371 | 0.200 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 17142 | 0.200 |
Why?
|
| Carbolines | 2 | 2014 | 295 | 0.180 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2021 | 199 | 0.180 |
Why?
|
| Protein Prenylation | 1 | 2020 | 70 | 0.180 |
Why?
|
| Colchicine | 1 | 2021 | 257 | 0.170 |
Why?
|
| Genes, Essential | 1 | 2021 | 185 | 0.170 |
Why?
|
| Small Molecule Libraries | 2 | 2018 | 742 | 0.170 |
Why?
|
| Lipid Peroxidation | 2 | 2017 | 276 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2021 | 839 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 719 | 0.130 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 3056 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 3428 | 0.120 |
Why?
|
| Cyclohexylamines | 1 | 2014 | 21 | 0.120 |
Why?
|
| Coumarins | 1 | 2014 | 119 | 0.110 |
Why?
|
| Phenylenediamines | 1 | 2014 | 89 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 6124 | 0.100 |
Why?
|
| Membrane Lipids | 1 | 2014 | 252 | 0.100 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2014 | 184 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10478 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2014 | 730 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2020 | 1266 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2271 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2152 | 0.080 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2009 | 53 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2021 | 23648 | 0.080 |
Why?
|
| Genes, ras | 1 | 2012 | 663 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 362 | 0.080 |
Why?
|
| Gentamicins | 1 | 2009 | 244 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1379 | 0.080 |
Why?
|
| Internet | 1 | 2021 | 3110 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 287 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1904 | 0.070 |
Why?
|
| Cytokines | 2 | 2021 | 7452 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2014 | 1147 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 10763 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3140 | 0.070 |
Why?
|
| Software | 1 | 2021 | 4480 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1009 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 942 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 606 | 0.060 |
Why?
|
| Th2 Cells | 1 | 2009 | 1078 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1767 | 0.050 |
Why?
|
| Piperazines | 1 | 2014 | 2554 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2100 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2094 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1901 | 0.050 |
Why?
|
| Microtubules | 2 | 2021 | 1064 | 0.050 |
Why?
|
| Humans | 14 | 2021 | 768171 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2021 | 121 | 0.050 |
Why?
|
| Triamterene | 1 | 2020 | 4 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3728 | 0.040 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2020 | 64 | 0.040 |
Why?
|
| Lovastatin | 1 | 2020 | 115 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4528 | 0.040 |
Why?
|
| Peritonitis | 1 | 2021 | 368 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2014 | 1884 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2747 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 381 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2017 | 74 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5804 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 186 | 0.030 |
Why?
|
| Mesoderm | 1 | 2017 | 679 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1247 | 0.030 |
Why?
|
| Methotrexate | 1 | 2020 | 1721 | 0.030 |
Why?
|
| Antioxidants | 1 | 2021 | 1676 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 644 | 0.030 |
Why?
|
| Smoking | 1 | 2009 | 9092 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 905 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 757 | 0.020 |
Why?
|
| Cell Survival | 2 | 2012 | 5789 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 71 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 466 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 405 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 281 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2009 | 39 | 0.020 |
Why?
|
| Thioglycolates | 1 | 2009 | 37 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
| Hair Removal | 1 | 2009 | 41 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1606 | 0.020 |
Why?
|
| Lipids | 1 | 2020 | 3345 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2009 | 267 | 0.020 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2009 | 117 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 938 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2009 | 193 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2009 | 348 | 0.020 |
Why?
|
| Dystrophin | 1 | 2009 | 284 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2017 | 2575 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22380 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2227 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 563 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 726 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 348 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2009 | 284 | 0.020 |
Why?
|
| Cell Line | 2 | 2011 | 15602 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2009 | 716 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6283 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 2059 | 0.020 |
Why?
|
| Mice | 4 | 2021 | 82049 | 0.020 |
Why?
|
| Thiophenes | 1 | 2011 | 570 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 825 | 0.020 |
Why?
|
| Drug Design | 1 | 2012 | 1046 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2014 | 945 | 0.020 |
Why?
|
| Epidermis | 1 | 2009 | 539 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 588 | 0.020 |
Why?
|
| Male | 4 | 2018 | 364731 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1524 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1832 | 0.020 |
Why?
|
| Oncogenes | 1 | 2011 | 1234 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 2300 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 910 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3251 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1169 | 0.010 |
Why?
|
| Animals | 5 | 2021 | 169285 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2009 | 1042 | 0.010 |
Why?
|
| Proteomics | 1 | 2017 | 3912 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13422 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5341 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 2414 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 2469 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4178 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2956 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3445 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20225 | 0.010 |
Why?
|
| Female | 1 | 2018 | 397187 | 0.010 |
Why?
|
| Melanoma | 1 | 2017 | 5706 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 3187 | 0.010 |
Why?
|
| Models, Biological | 1 | 2014 | 9497 | 0.010 |
Why?
|
| Pneumonia | 1 | 2009 | 2163 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7609 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9561 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8648 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 23782 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11101 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4978 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 10101 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 30237 | 0.000 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_